Moon ES - Search Results

1

Next generation fibroblast activation protein (FAP) targeting PET tracers - The tetrazine ligation allows an easy and convenient way to ¹⁸F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines.

Poulie CBM, Shalgunov V, Elvas F, Van Rymenant Y, Moon ES, Battisti UM, De Loose J, De Meester I, Rösch F, Van Der Veken P, Herth MM. Poulie CBM, et al. Among authors: moon es. Eur J Med Chem. 2023 Dec 15;262:115862. doi: 10.1016/j.ejmech.2023.115862. Epub 2023 Oct 14. Eur J Med Chem. 2023. PMID: 37883899 Free article.

2

[68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.

Kreppel B, Gärtner FC, Marinova M, Attenberger U, Meisenheimer M, Toma M, Kristiansen G, Feldmann G, Moon ES, Roesch F, Van Der Veken P, Essler M. Kreppel B, et al. Among authors: moon es. Nuklearmedizin. 2020 Sep;59(5):387-389. doi: 10.1055/a-1164-5667. Epub 2020 May 11. Nuklearmedizin. 2020. PMID: 32392592 English. No abstract available.

3

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA^5m chelators.

Moon ES, Elvas F, Vliegen G, De Lombaerde S, Vangestel C, De Bruycker S, Bracke A, Eppard E, Greifenstein L, Klasen B, Kramer V, Staelens S, De Meester I, Van der Veken P, Rösch F. Moon ES, et al. EJNMMI Radiopharm Chem. 2020 Jul 29;5(1):19. doi: 10.1186/s41181-020-00102-z. EJNMMI Radiopharm Chem. 2020. PMID: 32728930 Free PMC article.

4

⁶⁸Ga, ⁴⁴Sc and ¹⁷⁷Lu-labeled AAZTA⁵-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues.

Sinnes JP, Bauder-Wüst U, Schäfer M, Moon ES, Kopka K, Rösch F. Sinnes JP, et al. Among authors: moon es. EJNMMI Radiopharm Chem. 2020 Nov 26;5(1):28. doi: 10.1186/s41181-020-00107-8. EJNMMI Radiopharm Chem. 2020. PMID: 33242189 Free PMC article.

5

Effect of the versatile bifunctional chelator AAZTA⁵ on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist.

Hofstetter M, Moon ES, D'Angelo F, Geissbühler L, Alberts I, Afshar-Oromieh A, Rösch F, Rominger A, Gourni E. Hofstetter M, et al. Among authors: moon es. EJNMMI Radiopharm Chem. 2020 Nov 30;5(1):29. doi: 10.1186/s41181-020-00115-8. EJNMMI Radiopharm Chem. 2020. PMID: 33258012 Free PMC article.

6

Impact of prompt gamma emission of ⁴⁴Sc on quantification in preclinical and clinical PET systems.

Rosar F, Bohnenberger H, Moon ES, Rösch F, Denig A, Vincenz-Zörner D, Hoffmann MA, Khreish F, Ezziddin S, Schreckenberger M, Buchholz HG, Schaefer-Schuler A. Rosar F, et al. Among authors: moon es. Appl Radiat Isot. 2021 Apr;170:109599. doi: 10.1016/j.apradiso.2021.109599. Epub 2021 Jan 21. Appl Radiat Isot. 2021. PMID: 33515928

7

AAZTA⁵-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for ¹⁷⁷Lu-labeling of monoclonal antibodies under mild conditions.

Klasen B, Moon ES, Rösch F. Klasen B, et al. Among authors: moon es. Nucl Med Biol. 2021 May-Jun;96-97:80-93. doi: 10.1016/j.nucmedbio.2021.03.007. Epub 2021 Mar 26. Nucl Med Biol. 2021. PMID: 33839678

8

In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA⁵.SA.FAPi and DOTA.SA.FAPi.

Moon ES, Van Rymenant Y, Battan S, De Loose J, Bracke A, Van der Veken P, De Meester I, Rösch F. Moon ES, et al. Molecules. 2021 Jun 8;26(12):3482. doi: 10.3390/molecules26123482. Molecules. 2021. PMID: 34201111 Free PMC article.

9

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress.

Imlimthan S, Moon ES, Rathke H, Afshar-Oromieh A, Rösch F, Rominger A, Gourni E. Imlimthan S, et al. Among authors: moon es. Pharmaceuticals (Basel). 2021 Oct 5;14(10):1023. doi: 10.3390/ph14101023. Pharmaceuticals (Basel). 2021. PMID: 34681246 Free PMC article. Review.

10

Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time.

Moon ES, Ballal S, Yadav MP, Bal C, Van Rymenant Y, Stephan S, Bracke A, Van der Veken P, De Meester I, Roesch F. Moon ES, et al. Am J Nucl Med Mol Imaging. 2021 Dec 15;11(6):476-491. eCollection 2021. Am J Nucl Med Mol Imaging. 2021. PMID: 35003886 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page